News
Curaleaf fumes as Aurora considers other suitors
Published on October 20, 2026 by Pat Bulmer
Photo: Contributed Aurora Cannabis has made hostile suitor Curaleaf very angry.
After rejecting an enhanced offer from American-based giant, Edmonton-based Aurora indicated it might look for other partners — and that made Curaleaf’s top man, Boris Jordan, quite irate.
“Aurora’s response is grossly inadequate and negligent to its shareholders,” Jordan posted on X. “$ACB has stated it has begun a process with multiple parties yet is purposely excluding the largest cannabis company in the world that’s made a real bid with a clear path to value creation.
“$ACB is also questioning our synergies assumptions but are refusing to provide us due diligence access necessary to do just that.
“Make it make sense!”
Curaleaf recently raised its offer to Aurora shareholders from US$4 per share, mostly in shares, to US$5 per share, mostly in cash.
Aurora shares were trading at C$5.64 on the TSX on Oct. 16.
Organigram reportedly another possible bidder for Aurora
Aurora at first rejected Curaleaf’s new offer because it hadn’t been filed properly. Once Curaleaf filed the offer, Aurora rejected it again.
“Curaleaf’s revised offer still does not reflect the value of the company Aurora shareholders own today. Aurora is debt-free with a strong cash position, and we believe the revised Hostile Bid continues to ask shareholders to give up that strength, and their future upside, at a discount,” said Miguel Martin, Aurora CEO.
Almost buried in the fine print of a news release, Aurora added: “Superior proposals or other alternatives may emerge from Aurora’s ongoing strategic review process. Aurora shareholders are encouraged to wait for the results of that process. Tendering into the Hostile Bid could negatively affect the possibility of a superior alternative being available for Aurora shareholders to consider.”
Cultivated News reported, in a story behind a paywall, that Organigram might be a possible bidder.
Jordan didn’t like that either.
“If true, this is a travesty to the process and $ACB shareholders should demand SCURA get the same access as $OGI,” he posted. “What would $ACB shareholders rather own: currency of a small Canadian operator with limited scale or the currency of the global cannabis leader.”
Organigram hasn’t commented.
Curaleaf spurned by Aurora entertaining other companies
Curaleaf later put its objections into longer form in a news release.
“FACT: Aurora is giving others the keys while locking Curaleaf out of the building,” the release stated.
“Curaleaf – the only bidder with a binding offer for Aurora and real money on the table – continues to be denied diligence access despite repeated outreach and requests. Meanwhile, Aurora’s Notice of Change discloses that it “has entered into confidentiality and standstill agreements with a number of parties who have been examining confidential financial, operating and other relevant information relating to Aurora.’
“These are not the actions of a company that is serious about maximizing value for shareholders.”
The release goes on to challenge eight Aurora “myths.”
Meanwhile, regular business goes on.
Aurora announced it has completed expansion of a facility in Leuna, Germany. The site has been renamed Aurora Horizon. Aurora’s EU-certified plants are attractive assets to potential suitors.
Curaleaf continues to announce the opening of new dispensaries in various parts of the Eastern United States.
See our past stories on Curaleaf’s takeover attempt of Aurora.
Leave a comment on our Facebook page.
© Copyright 2026 Okanagan Z. | About the oz.
Report a Typo or Inaccuracy
We strive to avoid typos and inaccuracies. However, on occasion we make mistakes. We value your contributions and help in correcting them.